Small Molecule Inhibitors Targeting Methyltransferase-Like (METTL) Proteins Against Hepatocellular Carcinoma: A Comprehensive DrugRepurposing Approach
M. N. Morshed, M. S. A. Parvez, R. I. Akanda, M. K. Saha, J. Fardous, M. J. J. Hosen
This paper identifies two first-in-class inhibitors of METTL proteins with high potency and drug-likeness for hepatocellular carcinoma treatment.
bioRxiv · Mar 11, 2023 · PreprintCancer Biology